PNPLA3 and metabolic dysfunction-associated steatotic liver disease: The first genome-wide association (GWA) study for NAFLD used NAFLD cases diagnosed by liver fat content, and identified PNPLA3 as a major genetic determinant for fatty liver and triglyceride content[10] in Hispanic, African American, and European populations.